Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1987 1
1989 1
1991 7
1992 9
1993 10
1994 20
1995 18
1996 10
1997 12
1998 14
1999 4
2000 6
2001 4
2002 1
2003 5
2004 3
2005 11
2006 9
2007 5
2008 5
2009 7
2010 9
2011 9
2012 4
2013 10
2014 7
2015 9
2016 16
2017 10
2018 4
2019 7
2020 9
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

239 results
Results by year
Filters applied: . Clear all
Page 1
Acupuncture for benign prostatic hyperplasia: A systematic review and meta-analysis.
Zhang W, Ma L, Bauer BA, Liu Z, Lu Y. Zhang W, et al. PLoS One. 2017 Apr 4;12(4):e0174586. doi: 10.1371/journal.pone.0174586. eCollection 2017. PLoS One. 2017. PMID: 28376120 Free PMC article. Review.
PURPOSE: This systematic review and meta-analysis aims to assess the therapeutic and adverse effects of acupuncture for benign prostatic hyperplasia (BPH) in randomized controlled trials (RCTs). ...
PURPOSE: This systematic review and meta-analysis aims to assess the therapeutic and adverse effects of acupuncture for benign pro
Benign Prostatic Hyperplasia Implications for Pharmacologic Treatment and Perioperative Care.
Leedahl DD, Vo PH, Maxson PM, Lovely JK. Leedahl DD, et al. J Pharm Pract. 2013 Feb;26(1):52-8. doi: 10.1177/0897190012451913. Epub 2012 Jul 13. J Pharm Pract. 2013. PMID: 22797835 Review.
This review provides an update on the treatment of benign prostatic hyperplasia and the pharmacologic considerations for perioperative care. By age 85 years, approximately 90% of men have prostate histologic characteristics consistent with benign pr
This review provides an update on the treatment of benign prostatic hyperplasia and the pharmacologic considerations fo …
Paying the price for standing tall: Fluid mechanics of prostate pathology.
Gat Y, Joshua S, Vuk-Pavlović S, Goren M. Gat Y, et al. Prostate. 2020 Nov;80(15):1297-1303. doi: 10.1002/pros.24051. Epub 2020 Aug 24. Prostate. 2020. PMID: 32833288 Free PMC article. Review.
BACKGROUND: Age-dependent increase in the incidence of benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are both related to cell proliferation and survival controlled by intraprostatic free testosterone (FT) concentration. ...
BACKGROUND: Age-dependent increase in the incidence of benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are …
Benign prostatic hyperplasia: treat or wait?
Davidson JH, Chutka DS. Davidson JH, et al. J Fam Pract. 2008 Jul;57(7):454-63. J Fam Pract. 2008. PMID: 18625168 Review.
Rule out potential causes of lower urinary tract symptoms with a thorough medical history, focused physical exam (including digital rectal examination and neurological assessments), and appropriate laboratory evaluations. When choosing treatment for benign prostatic
Rule out potential causes of lower urinary tract symptoms with a thorough medical history, focused physical exam (including digital rectal e …
ACR Appropriateness Criteria Lower Urinary Tract Symptoms-Suspicion of Benign Prostatic Hyperplasia.
Expert Panel on Urological Imaging, Alexander LF, Oto A, Allen BC, Akin O, Chong J, Froemming AT, Fulgham PF, Goldfarb S, Maranchie JK, Mody RN, Patel BN, Schieda N, Schuster DM, Turkbey IB, Venkatesan AM, Wang CL, Lockhart ME. Expert Panel on Urological Imaging, et al. J Am Coll Radiol. 2019 Nov;16(11S):S378-S383. doi: 10.1016/j.jacr.2019.05.031. J Am Coll Radiol. 2019. PMID: 31685105 Review.
Lower urinary tract symptoms due to benign prostatic enlargement have a high prevalence in men over 50 years of age. ...
Lower urinary tract symptoms due to benign prostatic enlargement have a high prevalence in men over 50 years of age. ...
Risk factors for benign prostatic hyperplasia.
Jacobsen SJ. Jacobsen SJ. Curr Urol Rep. 2007 Jul;8(4):281-8. doi: 10.1007/s11934-007-0074-9. Curr Urol Rep. 2007. PMID: 18519012 Review.
This review summarizes recent findings regarding risk factors for benign prostatic hyperplasia (BPH), including new data on hormonal factors, growth factors, comorbid conditions and lifestyle, diet, and exercise as they relate to BPH. ...
This review summarizes recent findings regarding risk factors for benign prostatic hyperplasia (BPH), including new dat …
Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results.
Bhojani N, Bidair M, Zorn KC, Trainer A, Arther A, Kramolowsky E, Doumanian L, Elterman D, Kaufman RP, Lingeman J, Krambeck A, Eure G, Badlani G, Plante M, Uchio E, Gin G, Goldenberg L, Paterson R, So A, Humphreys M, Kaplan S, Motola J, Desai M, Roehrborn C. Bhojani N, et al. Urology. 2019 Jul;129:1-7. doi: 10.1016/j.urology.2019.04.029. Epub 2019 May 3. Urology. 2019. PMID: 31059728 Free article. Clinical Trial.
OBJECTIVE: To report 12-month safety and effectiveness outcomes of the Aquablation procedure for the treatment of men with symptomatic benign prostatic hyperplasia (BPH) and large-volume prostates. METHODS: One hundred and one men with moderate-to-severe BPH …
OBJECTIVE: To report 12-month safety and effectiveness outcomes of the Aquablation procedure for the treatment of men with symptomatic be
Electroresection and open surgery.
Thiel DD, Petrou SP. Thiel DD, et al. Urol Clin North Am. 2009 Nov;36(4):461-70, vi. doi: 10.1016/j.ucl.2009.08.001. Urol Clin North Am. 2009. PMID: 19942045 Review.
Transurethral resection of the prostate (TURP) is the historical gold standard therapy for lower urinary tract symptoms secondary to obstruction from benign prostatic hyperplasia (BPH). Over the last 15 years, medical therapy (alpha blockers and 5-alpha-reduc …
Transurethral resection of the prostate (TURP) is the historical gold standard therapy for lower urinary tract symptoms secondary to obstruc …
Medical treatment of benign prostatic hyperplasia: 5 alpha-reductase inhibitors and alpha-adrenergic antagonists.
Monda JM, Oesterling JE. Monda JM, et al. Mayo Clin Proc. 1993 Jul;68(7):670-9. doi: 10.1016/s0025-6196(12)60603-x. Mayo Clin Proc. 1993. PMID: 7688840 Review.
Benign prostatic hyperplasia (BPH), a nonmalignant neoplasm of the prostatic epithelial and stromal tissue, occurs commonly in elderly men. ...In some patients, this outcome decreases the mechanical obstruction of the prostatic urethra and impro
Benign prostatic hyperplasia (BPH), a nonmalignant neoplasm of the prostatic epithelial and stromal tissue, occu
Pharmacologic therapy for prostatism.
Lieber MM. Lieber MM. Mayo Clin Proc. 1998 Jun;73(6):590-6. doi: 10.4065/73.6.590. Mayo Clin Proc. 1998. PMID: 9621869 Review.
Although the general approach to management of a sufficient degree of benign prostatic hyperplasia in the past was surgical intervention (transurethral resection of the prostate), the current availability of effective pharmacologic therapy has changed the ini …
Although the general approach to management of a sufficient degree of benign prostatic hyperplasia in the past was surg …
239 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page